These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Once-weekly intraocular injections of ganciclovir for maintenance therapy of cytomegalovirus retinitis: clinical and ocular outcome. Hodge WG, Lalonde RG, Sampalis J, Deschênes J. J Infect Dis; 1996 Aug 07; 174(2):393-6. PubMed ID: 8699072 [Abstract] [Full Text] [Related]
9. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir. Drew WL, Stempien MJ, Andrews J, Shadman A, Tan SJ, Miner R, Buhles W. J Infect Dis; 1999 Jun 07; 179(6):1352-5. PubMed ID: 10228054 [Abstract] [Full Text] [Related]
12. Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. Jacobson MA, Wulfsohn M, Feinberg JE, Davis R, Power M, Owens S, Causey D, Heath-Chiozzi ME, Murphy RL, Cheung TW. AIDS; 1994 Apr 07; 8(4):451-9. PubMed ID: 8011248 [Abstract] [Full Text] [Related]
15. Treatment of recurrent cytomegalovirus retinitis with the ganciclovir implant. Roth DB, Feuer WJ, Blenke AJ, Davis JL. Am J Ophthalmol; 1999 Mar 07; 127(3):276-82. PubMed ID: 10088736 [Abstract] [Full Text] [Related]
16. Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS. Lee TA, Sullivan SD, Veenstra DL, Ramsey SD, Steger PJ, Malinverni R, Pleil AM, Williamson T. Pharmacoeconomics; 2001 Mar 07; 19(5 Pt 2):535-50. PubMed ID: 11465299 [Abstract] [Full Text] [Related]
17. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Ophthalmology; 1994 Jul 07; 101(7):1250-61. PubMed ID: 8035989 [Abstract] [Full Text] [Related]
18. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela. Arevalo JF, Garcia RA, Mendoza AJ. Eur J Ophthalmol; 2005 Jul 07; 15(5):610-8. PubMed ID: 16167292 [Abstract] [Full Text] [Related]
19. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. Studies of Ocular Complications of AIDS Research Group. The AIDS Clinical Trials Group.. Am J Ophthalmol; 2001 Apr 07; 131(4):457-67. PubMed ID: 11292409 [Abstract] [Full Text] [Related]